- Enrollment to-date of 52 patients in the ongoing Halneuron® Phase 2b Trial - - Halneuron® Chemotherapy-Induced Neuropathic Pain (“CINP”)…
- Enrollment to-date of 52 patients in the ongoing Halneuron® Phase 2b Trial - - Halneuron® Chemotherapy-Induced Neuropathic Pain (“CINP”)…
Fiscal Q1 2026 net revenue of $24.6 million, net income of $0.5 million, operating income of $0.9 million, and Adjusted…
Founded by a team of physicians and AI experts, EasyPA launched the nation's first fully operational prior authorization (PA) platform…
Technology-enabled solution expands access to high-touch, personalized dementia care at home BOSTON, Aug. 12, 2025 /PRNewswire/ -- Neuroglee Health, a…
- Revenue of $1.9 Million consistent with the year-ago period- Revenue led by Population Health's growth up 197% compared to…
ALBANY, N.Y., Aug. 12, 2025 /PRNewswire/ -- Hixny has been awarded a contract by the Statewide Health Information Network for…
NEW YORK, NY / ACCESS Newswire / August 12, 2025 / Inc., the leading media brand and playbook for the…
TEMPE, Ariz., Aug. 7, 2025 /PRNewswire/ -- Economic activity in the hospital subsector expanded in July after one month of contraction, preceded…
Cantata's Modern EHR Platform Will Empower Outreach to Expand its Impact in Communities of Need LAKEWAY, Texas, Aug. 7, 2025…